| [1] |
韦静涛，季鑫，季加孚. 不断提高中国胃癌外科手术治疗规范化[J/CD]. 中华普外科手术学杂志（电子版）, 2022, 16(03): 237–241.
|
| [2] |
Sung H，Ferlay J，Siegel RL，et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209–249.
|
| [3] |
陈凛，李少卿，张珂诚. 中国腹腔镜胃癌手术20年回顾与展望[J/CD]. 中华普外科手术学杂志（电子版）, 2021, 15(02): 119–122.
|
| [4] |
陈纲，吕远，李世拥. 腹腔镜胃癌根治术需关注的几个问题[J/CD]. 中华普外科手术学杂志（电子版）, 2022, 16(03): 251–254.
|
| [5] |
Vaes N，Idris M，Boesmans W，et al. Nerves in gastrointestinal cancer: from mechanism to modulations[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(12): 768–784.
|
| [6] |
Oya Y，Hayakawa Y，Koike K. Tumor microenvironment in gastric cancers[J]. Cancer Sci, 2020, 111(8): 2696–2707.
|
| [7] |
Szeliga A，Rudnicka E，Maciejewska-Jeske M，et al. Neuroendocrine Determinants of Polycystic Ovary Syndrome[J]. Int J Environ Res Public Health, 2022, 19(5): 3089.
|
| [8] |
Kraft RO，Myers J，Overton S，et al. Vagotomy and the gastric ulcer[J]. The American Journal of Surgery, 1971, 121(2): 122–128.
|
| [9] |
Kamiya A，Hiyama T，Fujimura A，et al. Sympathetic and parasympathetic innervation in cancer: therapeutic implications[J]. Clin Auton Res, 2021, 31(2): 165–178.
|
| [10] |
Wang K，Zhao XH，Liu J，et al. Nervous system and gastric cancer[J]. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188313.
|
| [11] |
Bakst RL，Glastonbury CM，Parvathaneni U，et al. Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer[J]. Int J Radiat Oncol Biol Phys, 2019, 103(5): 1109–1124.
|
| [12] |
Jiang SH，Zhang S，Wang H，et al. Emerging experimental models for assessing perineural invasion in human cancers[J]. Cancer Lett, 2022, 535: 215610.
|
| [13] |
Liu Q，Ma Z，Cao Q，et al. Perineural invasion-associated biomarkers for tumor development[J]. Biomed Pharmacother, 2022, 155: 113691.
|
| [14] |
Schledwitz A，Xie G，Raufman JP. Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer[J]. J Clin Invest, 2021, 131(10): e143776.
|
| [15] |
Wang L，Xu J，Xia Y，et al. Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer[J]. Oncogenesis, 2018, 7(11): 88.
|
| [16] |
Hering NA，Liu V，Kim R，et al. Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma[J]. Cancers（Basel）, 2021, 13(13): 3220.
|
| [17] |
Yu H，Xia H，Tang Q，et al. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation[J]. Sci Rep, 2017, 7: 40802.
|
| [18] |
Nie M，Chen N，Pang H，et al. Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse[J]. J Clin Invest, 2022, 132(20): e160152.
|
| [19] |
Hayakawa Y，Sakitani K，Konishi M，et al. Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling[J]. Cancer Cell, 2017, 31(1): 21–34.
|
| [20] |
Kuol N，Stojanovska L，Apostolopoulos V，et al. Crosstalk between cancer and the neuro-immune system[J]. J Neuroimmunol, 2018, 315: 15–23.
|
| [21] |
崔伟，李涛，李世拥. 中国腹腔镜胃癌手术20年历程与成就[J/CD]. 中华普外科手术学杂志（电子版）, 2021, 15(02): 139–142.
|
| [22] |
Zhang X，Zhang Y，He Z，et al. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2[J]. Cell Death Dis, 2019, 10(11): 788.
|
| [23] |
Silva D，Quintas C，Goncalves J，et al. Contribution of adrenergic mechanisms for the stress-induced breast cancer carcinogenesis[J]. J Cell Physiol, 2022, 237(4): 2107–2127.
|
| [24] |
Batalla-Covello J，Ali S，Xie T，et al. beta-Adrenergic signaling in skin cancer[J]. FASEB Bioadv, 2022, 4(4): 225–234.
|
| [25] |
Zhi X，Li B，Li Z，et al. Adrenergic modulation of AMPK‑dependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer[J]. Int J Oncol, 2019, 54(5): 1625–1638.
|
| [26] |
Shi M，Liu D，Duan H，et al. Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer[J]. Mol Cancer, 2010, 9: 269.
|
| [27] |
Ogawa H，Kaira K，Motegi Y，et al. Prognostic significance of beta2-adrenergic receptor expression in patients with surgically resected colorectal cancer[J]. Int J Clin Oncol, 2020, 25(6): 1137–1144.
|
| [28] |
Bucsek MJ，Qiao G，MacDonald CR，et al. β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8（+）T Cells and Undermines Checkpoint Inhibitor Therapy[J]. Cancer Res, 2017, 77(20): 5639–5651.
|
| [29] |
Chen J，Li J，Qiao H，et al. Disruption of IDO signaling pathway alleviates chronic unpredictable mild stress-induced depression-like behaviors and tumor progression in mice with breast cancer[J]. Cytokine, 2023, 162: 156115.
|
| [30] |
Huang D，Wang Y，Thompson JW，et al. Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression[J]. Nat Cell Biol, 2022, 24(2): 230–241.
|
| [31] |
Hanahan D，Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment[J]. Cancer Cell, 2023, 41(3): 573–580.
|
| [32] |
Bruno F，Arcuri D，Vozzo F，et al. Expression and Signaling Pathways of Nerve Growth Factor（NGF）and Pro-NGF in Breast Cancer: A Systematic Review[J]. Curr Oncol, 2022, 29(11): 8103–8120.
|
| [33] |
Lei Y，He X，Huang H，et al. Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis[J]. Clin Transl Oncol, 2022, 24(1): 34–47.
|
| [34] |
Ghatak S，Mehrabi SF，Mehdawi LM，et al. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers[J]. Int J Mol Sci, 2022, 23(2).
|
| [35] |
Allen JK，Armaiz-Pena GN，Nagaraja AS，et al. Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction[J]. Cancer Res, 2018, 78(12): 3233–3242.
|
| [36] |
Park GB，Choi S，Yoon YS，et al. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells[J]. Mol Med Rep, 2021, 23(6).
|
| [37] |
Zahalka AH，Frenette PS. Nerves in cancer[J]. Nat Rev Cancer, 2020, 20(3): 143–157.
|
| [38] |
Chen D，Zhang X，Li Z，et al. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages[J]. Theranostics, 2021, 11(3): 1016–1030.
|
| [39] |
Mehla K，Singh PK. Metabolic Regulation of Macrophage Polarization in Cancer[J]. Trends Cancer. 2019, 5(12): 822–834.
|
| [40] |
Mantovani A，Allavena P，Sica A，et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436–444.
|
| [41] |
Cortese N，Rigamonti A，Mantovani A，et al. The neuro-immune axis in cancer: Relevance of the peripheral nervous system to the disease[J]. Immunol Lett, 2020, 227: 60–65.
|
| [42] |
Zhang N，Cao M，Duan Y，et al. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis and experimental validation[J]. Arch Med Sci, 2020, 16(5): 1092–1103.
|
| [43] |
Qiao G，Bucsek MJ，Winder NM，et al. beta-Adrenergic signaling blocks murine CD8（+）T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress[J]. Cancer Immunol Immunother, 2019, 68(1): 11–22.
|
| [44] |
Dai S，Mo Y，Wang Y，et al. Chronic Stress Promotes Cancer Development[J]. Front Oncol, 2020, 10: 1492.
|
| [45] |
Wu Y，Yuan M，Wang C，et al. T lymphocyte cell: A pivotal player in lung cancer[J]. Front Immunol, 2023, 14: 1102778.
|
| [46] |
Laumont CM，Banville AC，Gilardi M，et al. Tumour-infiltrating B cells: immunological mechanisms，clinical impact and therapeutic opportunities[J]. Nat Rev Cancer, 2022, 22(7): 414–430.
|